Time-resolved immunofluorometric assay of complement C3: application to cerebrospinal fluid

Area of Science:

• Neuroscience
• Immunology
• Biochemistry

Background:

• Complement components, including C3, are implicated in neurological disorders.
• Measuring low concentrations of C3 in cerebrospinal fluid (CSF) requires sensitive immunochemical methods.
• Existing sensitive methods like radioimmunoassays are isotopic, posing limitations.

Purpose of the Study:

• To develop and validate a novel sandwich-type time-resolved immunofluorometric assay (TR-IFMA) for quantifying complement C3 in human CSF.
• To establish TR-IFMA as a sensitive, nonisotopic alternative to traditional methods for C3 measurement in CSF.

Main Methods:

• Development of a sandwich-type time-resolved immunofluorometric assay (TR-IFMA).
• Assay validation for linearity, intra-assay precision, and inter-assay precision using CSF samples.
• Comparison of TR-IFMA results with electroimmunodiffusion assays (EID).

Main Results:

• The TR-IFMA demonstrated excellent linearity across a wide range (0.7-3650 µg/L).
• Satisfactory precision was achieved with intra-assay CV < 4.8% and inter-assay CV < 10.9%.
• The assay exhibited high sensitivity (< 1 µg/L) and results correlated well with EID.

Conclusions:

• The developed TR-IFMA is a highly sensitive and precise method for quantifying complement C3 in CSF.
• This nonisotopic assay provides a valuable alternative to radioimmunoassays for clinical applications in neurological research.
• TR-IFMA is suitable for measuring low C3 concentrations in CSF, aiding the study of neurological disorders.